103% Surge in 10 Days: What Does China Boton 2023 Performance Report Reveal?

Business by 2FIRSTS
Mar.27.2024
103% Surge in 10 Days: What Does China Boton 2023 Performance Report Reveal?
E-cigarette-related HK-listed firms, like Smoore Int'l (6969.HK) and China Boton (3318.HK), see significant stock price increases in March.

In March, the stock prices of several e-cigarette related businesses listed on the Hong Kong stock market, such as Smoore International (6969.HK) and China Boton (3318.HK), have experienced significant increases. China Boton, in particular, saw its stock price soar from an opening price of 0.95 on March 12 to a closing price of 1.93 on March 22, effectively doubling its market value and approaching one billion Hong Kong dollars. (Note: As of the time of writing, China Boton's stock price on the morning of March 27 has fallen back to 1.670)

 

Will e-cigarette companies like Fonton, which is a leading representative, experience a bottoming out rebound in the capital market in the future? 2FIRSTS conducted a research analysis on Fonton's latest performance report and its recent years.

 

Overview of China Boton

 

Boton Group, founded in 2005 with a focus on tobacco flavorings, successfully went public on the Hong Kong Stock Exchange in the same year. It was the first Chinese flavor and fragrance company to be listed in Hong Kong. With a long-term commitment to expanding horizontally in the flavor and fragrance industry, Bodun Group now covers tobacco, food, and daily use fragrances. In 2015, the company acquired Jirui and Ince-cigarette, marking its official entry into the e-cigarette market.

 

After successfully acquiring Jirui e-cigarette, its e-cigarette division has experienced rapid growth in performance, increasing from 1.54 billion yuan in 2016 to 11.65 billion yuan in 2022, with a compound annual growth rate of 40.1%, contributing to the continued growth of revenue.

 

It is worth noting that Botton has always maintained a good relationship with China Tobacco. The first domestic HNB tobacco product "Kuanzhai Kung Fu" in China was developed by China Tobacco Sichuan and manufactured by Botton's Huizhou factory. It has been launched in foreign markets. The domestically produced IQOS device GS5.0 is also a product of cooperation between Botton and China Tobacco.

 

However, the operating profit margin of the e-cigarette sector is lower than that of the flavor enhancer sector. The rapid increase in the e-cigarette sector's market share has caused China Boton's overall gross profit margin to gradually decline in recent years.

 

Highlights of the Financial Report

 

In 2022, the company achieved a net profit attributable to shareholders of 0.48 billion yuan, a sharp drop of 73.67% compared to the previous year. The net profit margin for the year was 3.6%, leading many to question whether its profitability is not as strong as its revenue performance.

 

From a detailed analysis of the various business segments, the company's decline in performance during the period was mainly attributed to the drag of e-cigarette products. The revenue contribution from this segment in the first half of the year decreased by a significant 41.2% compared to the same period last year.

 

Potton, a Chinese e-cigarette company, attributes the decline in revenue from its e-cigarette business to new policies and tax rates implemented by the Chinese government on different e-cigarette products. Additionally, the company has allocated a significant amount of manpower and resources to comply with these regulations, resulting in increased costs and expenses.

 

In the financial report released on March 22, covering the fiscal year ending on December 31, 2023, Bolton reported a total annual revenue of 2.064 billion yuan. The company's net profit attributable to owners reached 146 million yuan, a year-on-year increase of 202.94%. Earnings per share stood at 0.14 yuan.

 

103% Surge in 10 Days: What Does China Boton 2023 Performance Report Reveal?

 

As of the fiscal year ending on December 31, 2023, the company's net profit was approximately 141 million RMB, a year-on-year increase of 66.5%. According to the report, this increase was mainly due to the profit from selling two Korean subsidiaries of the group during the fiscal year; and a decrease in the provision for litigation claims offset by the net loss of impairment of financial assets. The company's net profit margin for the year also increased from 3.6% in the previous year to approximately 6.8%.

 

Compliance-driven Rebound?

 

Tighter regulations and the implementation of a consumption tax have put pressure on the e-cigarette industry in the short term. This is a key factor contributing to the declining performance of China Boton, Smoore International in the first half of 2022 and 2023.

 

A senior industry insider from a sponsoring institution revealed to 2FIRSTS that the e-cigarette concept had previously experienced a surge in value and then returned to normal levels. This was partly in response to tightened policies and partly a natural part of the industry's development process. However, from a long-term perspective, the implementation of regulatory policies and the establishment of a regulatory framework for e-cigarettes in China will promote the industry's entry into a period of orderly development. Strengthened regulation will also benefit the industry by eliminating inferior and illegal small businesses, signaling a positive trend for the overall market's future healthy growth.

 

The performance and stock price of China Boton in the future will be worth paying attention to in order to see if they can capitalize on the opportunities in the industry and rise accordingly.

 

2FIRSTS will continue to monitor the performance of e-cigarette related companies and sectors in the capital market.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
A new expert paper in JAMA urges U.S. clinicians to include nicotine e-cigarettes in smoking-cessation discussions, citing higher quit rates than nicotine replacement therapy. It also stresses that products must deliver enough nicotine to replace cigarettes, dual use should be brief, and complete switching is the goal. 2Firsts argues the recommendations matter beyond clinics: public-health professionals should reassess relative risk, regulators should preserve sufficient product appeal for adult smokers, and manufacturers should focus on helping users quit cigarettes more sustainably.
SCIENCE
Aug.03 by 2Firsts Perspectives
BAT Calls for Retailer Input in Future Nicotine Regulations
BAT Calls for Retailer Input in Future Nicotine Regulations
British American Tobacco (BAT) has called for stronger retailer involvement in shaping future nicotine product regulations in the UK, arguing that frontline market feedback should be considered during policy development. BAT said retailers provide direct insight into consumer behavior, market changes and regulatory implementation challenges. The comments come as the UK nicotine market undergoes regulatory changes, including the disposable vape ban, Vaping Products Duty and efforts to address illicit vape sales.
Jul.29
Nasdaq-Listed Vape Company iSpire Technology Restructures Leadership as Tuanfang Liu Becomes Sole CEO, BTIG Initiates Coverage on ODM Growth Opportunity
Nasdaq-Listed Vape Company iSpire Technology Restructures Leadership as Tuanfang Liu Becomes Sole CEO, BTIG Initiates Coverage on ODM Growth Opportunity
Nasdaq-listed vape company iSpire Technology has restructured its leadership team, with Tuanfang Liu becoming the company’s sole chief executive officer (CEO) and Michael Wang appointed CEO of Aspire North America. The move ends iSpire’s previous co-CEO structure and creates clearer responsibilities between group strategy and regional execution. Separately, BTIG initiated coverage on iSpire Technology with a Buy rating and a $3.50 price target, identifying ODM growth opportunities as a key investment factor.
Jul.27
PMI Expands Colorado Investment to $1.2 Billion to Boost ZYN Nicotine Pouch Production
PMI Expands Colorado Investment to $1.2 Billion to Boost ZYN Nicotine Pouch Production
Philip Morris International (PMI) is expanding its investment in its Golden, Colorado campus, bringing total investment to approximately $1.2 billion to support its smoke-free products business. The investment will strengthen PMI’s research, production and innovation capabilities in smoke-free products. As one of the world’s largest tobacco companies, PMI has continued advancing its “Smoke-Free Future” strategy through heated tobacco, oral nicotine and other reduced-risk product categories.
PMI
Jul.28
Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
According to Irish media outlets Highland Radio and BreakingNews.ie, the Irish government is considering whether to adjust vape tax policy in the 2027 Budget. The tax has generated about €22 million ($24 million) in revenue during its first nine months. While no increase has been confirmed, the revenue performance could influence future fiscal discussions. Any tax rise could increase product costs and potentially affect retail prices.
Aug.12
Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria’s second-quarter results show a U.S. nicotine market splitting across price, product and regulation. Smokeable profit rose 2.4% as Marlboro pricing offset lower volumes, while discount brand Basic gained share among value-conscious smokers. In oral nicotine, on! PLUS expanded distribution but faced intensifying competition from ZYN and Velo. NJOY remained off the market as patent and regulatory hurdles delayed its return. The broader lesson: U.S. growth increasingly depends on price-tier strategy, retail execution, authorisation and enforcement readiness across the industry.
Special Report
Jul.31